Acceleron And Fulcrum Therapeutics Announce Pulmonary Research And Discovery Collaboration Agreement; Fulcrum To Receive $10M Upfront Payment And Milestones Of Up To $295M For First Commercialized Product And Up To $143.5M For Subsequent Products
Benzinga Newsdesk